Afuco™ Anti-Human REG4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-REG4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The novel anti-RELP fusion antibody target provides a method for modulating or treating at least one RELP protein related disease, such as leukemia, lymphoma, carcinoma, solid tumors.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-725CL |
| Pricing | Inquiry |
| Host | Human |
| Target | REG4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |